# Ph II Study of Azacitidine in Myelofibrosis

> **NCT00569660** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 34 (actual)

## Conditions studied

- Myelofibrosis

## Interventions

- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT00569660
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2012-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569660, "Ph II Study of Azacitidine in Myelofibrosis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00569660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*